Literature DB >> 21925292

Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.

Vivian Hook1, Lydiane Funkelstein, Jill Wegrzyn, Steven Bark, Mark Kindy, Gregory Hook.   

Abstract

Recent new findings indicate significant biological roles of cysteine cathepsin proteases in secretory vesicles for production of biologically active peptides. Notably, cathepsin L in secretory vesicles functions as a key protease for proteolytic processing of proneuropeptides (and prohormones) into active neuropeptides that are released to mediate cell-cell communication in the nervous system for neurotransmission. Moreover, cathepsin B in secretory vesicles has been recently identified as a β-secretase for production of neurotoxic β- amyloid (Aβ) peptides that accumulate in Alzheimer's disease (AD), participating as a notable factor in the severe memory loss in AD. These secretory vesicle functions of cathepsins L and B for production of biologically active peptides contrast with the well-known role of cathepsin proteases in lysosomes for the degradation of proteins to result in their inactivation. The unique secretory vesicle proteome indicates proteins of distinct functional categories that provide the intravesicular environment for support of cysteine cathepsin functions. Features of the secretory vesicle protein systems insure optimized intravesicular conditions that support the proteolytic activity of cathepsins. These new findings of recently discovered biological roles of cathepsins L and B indicate their significance in human health and disease. This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925292      PMCID: PMC3232284          DOI: 10.1016/j.bbapap.2011.08.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  116 in total

1.  Electron histochemical localization of cathepsin L in the liver.

Authors:  V V Ryvnyak; E I Ryvnyak; R V Tudos
Journal:  Bull Exp Biol Med       Date:  2004-01       Impact factor: 0.804

2.  Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.

Authors:  R Yan; M J Bienkowski; M E Shuck; H Miao; M C Tory; A M Pauley; J R Brashier; N C Stratman; W R Mathews; A E Buhl; D B Carter; A G Tomasselli; L A Parodi; R L Heinrikson; M E Gurney
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

3.  Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis.

Authors:  Xin Zhang; Hui Pan; Bonnie Peng; Donald F Steiner; John E Pintar; Lloyd D Fricker
Journal:  J Neurochem       Date:  2009-12-07       Impact factor: 5.372

4.  Regulation of amyloid precursor protein secretion by glutamate receptors in human Ntera 2 neurons.

Authors:  C Jolly-Tornetta; Z Y Gao; V M Lee; B A Wolf
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

Review 5.  The role of neuropeptide Y in cardiovascular regulation.

Authors:  P Walker; E Grouzmann; M Burnier; B Waeber
Journal:  Trends Pharmacol Sci       Date:  1991-03       Impact factor: 14.819

6.  Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease.

Authors:  Vivian Hook; Thomas Toneff; Matthew Bogyo; Doron Greenbaum; Katalin F Medzihradszky; John Neveu; William Lane; Gregory Hook; Terry Reisine
Journal:  Biol Chem       Date:  2005-09       Impact factor: 3.915

Review 7.  The role of NPY in metabolic homeostasis: implications for obesity therapy.

Authors:  H A Wieland; B S Hamilton; B Krist; H N Doods
Journal:  Expert Opin Investig Drugs       Date:  2000-06       Impact factor: 6.206

8.  Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics.

Authors:  Jonathan H Wardman; Xin Zhang; Sandra Gagnon; Leandro M Castro; Xiaorong Zhu; Donald F Steiner; Robert Day; Lloyd D Fricker
Journal:  J Neurochem       Date:  2010-04-19       Impact factor: 5.372

9.  Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter.

Authors:  Sukkid Yasothornsrikul; Doron Greenbaum; Katalin F Medzihradszky; Thomas Toneff; Richard Bundey; Ruthellen Miller; Birgit Schilling; Ivonne Petermann; Jessica Dehnert; Anna Logvinova; Paul Goldsmith; John M Neveu; William S Lane; Bradford Gibson; Thomas Reinheckel; Christoph Peters; Matthew Bogyo; Vivian Hook
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-17       Impact factor: 11.205

10.  Isoaspartate-containing amyloid precursor protein-derived peptides alter efficacy and specificity of potential beta-secretases.

Authors:  Livia Böhme; Torsten Hoffmann; Susanne Manhart; Raik Wolf; Hans-Ulrich Demuth
Journal:  Biol Chem       Date:  2008-08       Impact factor: 3.915

View more
  25 in total

Review 1.  Actin dynamics and cofilin-actin rods in alzheimer disease.

Authors:  James R Bamburg; Barbara W Bernstein
Journal:  Cytoskeleton (Hoboken)       Date:  2016-03-01

Review 2.  Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.

Authors:  Klaudia Brix; Joseph McInnes; Alaa Al-Hashimi; Maren Rehders; Tripti Tamhane; Mads H Haugen
Journal:  Protoplasma       Date:  2014-11-16       Impact factor: 3.356

3.  Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.

Authors:  Yisel Cantres-Rosario; Marines Plaud-Valentín; Yamil Gerena; Richard L Skolasky; Valerie Wojna; Loyda M Meléndez
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

4.  Cathepsin B regulates hepatic lipid metabolism by cleaving liver fatty acid-binding protein.

Authors:  Simeon Thibeaux; Shaila Siddiqi; Olga Zhelyabovska; Faisal Moinuddin; Michal M Masternak; Shadab A Siddiqi
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

5.  Molecular dynamics simulation of halogen bonding mimics experimental data for cathepsin L inhibition.

Authors:  Cristian Celis-Barros; Leslie Saavedra-Rivas; J Cristian Salgado; Bruce K Cassels; Gerald Zapata-Torres
Journal:  J Comput Aided Mol Des       Date:  2014-10-22       Impact factor: 3.686

6.  Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.

Authors:  Robert J Baranello; Krishna L Bharani; Vasudevaraju Padmaraju; Nipun Chopra; Debomoy K Lahiri; Nigel H Greig; Miguel A Pappolla; Kumar Sambamurti
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

Review 7.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

Review 8.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

9.  Theoretical insight into the mechanism for the inhibition of the cysteine protease cathepsin B by 1,2,4-thiadiazole derivatives.

Authors:  Mauricio Angel Vega-Teijido; Sarah El Chamy Maluf; Camila Ramalho Bonturi; Julio Ricardo Sambrano; Oscar N Ventura
Journal:  J Mol Model       Date:  2014-06-01       Impact factor: 1.810

10.  β-Secretases, Alzheimer's Disease, and Down Syndrome.

Authors:  Robin L Webb; M Paul Murphy
Journal:  Curr Gerontol Geriatr Res       Date:  2012-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.